Hold Ahmedabad official liable for Covid-19 spread: PIL | WeForNews | Latest News, Blogs Hold Ahmedabad official liable for Covid-19 spread: PIL – WeForNews | Latest News, Blogs
Connect with us

Disaster

Hold Ahmedabad official liable for Covid-19 spread: PIL

The petitioner also cited Prime Minister Narendra Modi’s appeal to the people to not start stocking and hoarding essential commodities and the state governments will make available adequate stock of essentials.

Published

on

coronavirus india

Gandhinagar, May 10 : A public interest litigation (PIL) has been filed in the Gujarat High Court, seeking declaration of the Ahmedabad Municipal Commissioner solely responsible for causing Covid-19 spread because of his sudden and illegal order of total lockdown in Ahmedabad.

It forced Ahmedabad residents to come onto the street in large numbers to buy essentials, it said.

Harshit Indravadan Shah, an Ahmedabad resident, has filed the petition against the state government and Ahmedabad Municipal Commissioner Mukesh Kumar for issuing the order, prohibiting vegetable shops and grocery shops to operate in the city from 7 p.m. of May 6.

Shah said the sudden order caused huge mental and physical harassment to Ahmedabad residents and was illegal, arbitrary and unreasonable and in violation of the Article 21 of the Constitution.

Seeking the court’s direction on declaring Kumar solely accountable for large outbreak of coronavirus as his order caused panic among people, forcing them onto the streets in large numbers and overcrowding groceries and vegetable vendors on May 6 evening.

Kumar had issued the circular, ordering shutdown of all shops, including groceries and vegetable vendors, in Ahmedabad, except milk and medicine outlets. The petitioner has said the Commissioner didn’t provide any option to the residents for fruits & vegetable or groceries.

The petitioner also cited Prime Minister Narendra Modi’s appeal to the people to not start stocking and hoarding essential commodities and the state governments will make available adequate stock of essentials. The people had believed in the Prime Minister and didn’t stock, he added.

Cities

Uttar Pradesh: Corona reaches Speaker’s office in Vidhan Sabha

Leader of Opposition Ram Govind Chaudhary is also being treated for Corona in SGPGIMS.

Published

on

UP Assembly

Lucknow, July 13 : The Covid-19 infection has reached the Uttar Pradesh Vidhan Sabha.

UP Speaker Hriday Narain Dixit’s OSD Pankaj Mishra and his personal secretary Ajay Pratap Singh have tested positive for the Coronavirus.

Mishra has been admitted to the Sanjay Gandhi Post Graduate Institute of Medical Sciences (SGPGIMS) while Ajay Pratap Singh has been admitted to the Lohia Institute of Medical Sciences.

The Speaker”s Corona test report, however, shows that he is negative.

The Speaker has asked all those who came in contact with him and his staff to get themselves tested. He has also quarantined himself.

Five ministers of the Yogi government have already tested positive for Corona.

UP ministers Rajendra Pratap Singh, Dharam Singh Saini, Chetan Chauhan, Upendra Tiwari and Raghuraj Singh have tested positive for Corona and are under treatment.

Leader of Opposition Ram Govind Chaudhary is also being treated for Corona in SGPGIMS.

Continue Reading

Disaster

Glenmark cuts Fabiflu price by 27%

On June 20, Glenmark announced that it received manufacturing and marketing approval from India”s drug regulator for FabiFlu, making it the first oral Favipiravir-approved medication in India for the treatment of mild to moderate COVID-19.

Published

on

By

Glenmark Fabiflu

New Delhi, July 13 : Glenmark Pharmaceuticals has announced that it has commenced a Post Marketing Surveillance (PMS) study on FabiFlu to closely monitor the efficacy and safety of the drug in 1000 Covid patients that are prescribed with the oral antiviral.

Further, Glenmark has announced a price reduction of 27 per cent for FabiFlu. The new MRP is Rs 75 per tab from the earlier Rs 103 per tab.

The price reduction has been made possible through benefits gained from higher yields and better scale, as both the API and formulations are made at Glenmark”s facilities in India, the benefits of which are being passed on to patients in the country.

Glenmark has successfully developed the active pharmaceutical ingredient (API) and the formulation for FabiFlu through its own in-house R&D team within the country, ensuring self-reliance with regard to long term production and manufacturing.

Commenting on these developments, Alok Malik, Senior Vice President & Head – India business, Glenmark Pharmaceuticals said, “We expect this post marketing surveillance study to shed more light on the drug”s clinical effectiveness and safety in a large cohort of patients prescribed FabiFlu. Our priority from the start of this pandemic has been to offer patients in India an effective treatment for COVID-19, while also ensuring accessibility to the masses.

“Our internal research shows us that we launched FabiFlu in India at the lowest market cost as compared to the cost of Favipiravir in other countries where it is approved. And now we hope that this further price reduction will make it even more accessible for patients across the country.”

Despite investing significantly in R&D, clinical trials and the manufacturing of FabiFlu (API and formulations), Glenmark has managed to keep the pricing of FabiFlu lower as compared to its price in other countries.

FabiFlu in India was originally launched at Rs 103 per tablet, while, its price in Indian Rupees is higher in the remaining countries like Rs 600 in Russia, Rs 378 in Japan, Rs 350 in Bangladesh and Rs 215 in China.

On June 20, Glenmark announced that it received manufacturing and marketing approval from India”s drug regulator for FabiFlu, making it the first oral Favipiravir-approved medication in India for the treatment of mild to moderate COVID-19.

The manufacturing and marketing approval was granted as part of accelerated approval process, considering the emergency situation of the COVID-19 outbreak in India. The approval”s restricted use entails responsible medication use where every patient must have signed informed consent before treatment initiation.

Continue Reading

Cities

Sachin Pilot’s office sealed in Jaipur

Pilot is in Delhi and has triggered a political storm by declaring that the Ashok Gehlot-led Congress government in Rajasthan is in crisis as a total of 30 MLAs are supporting his camp.

Published

on

By

Rajasthan Congress chief Sachin Pilot.

Jaipur, July 13 : Rajasthan Deputy Chief Minister and Congress leader Sachin Pilot’s office here has been reportedly sealed on Sunday after two employees of the department tested positive for Covid-19.

The Panchayati Raj and Rural Development headquarters being headed by Pilot will remain sealed on July 13 and 14, said officials, adding that the staff shall remain available on phone.

Pilot is in Delhi and has triggered a political storm by declaring that the Ashok Gehlot-led Congress government in Rajasthan is in crisis as a total of 30 MLAs are supporting his camp.

Continue Reading
Advertisement

Most Popular